|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...8384858687888990919293...110111» |
- propranolol / Generic mfg.
Trial initiation date, IO biomarker: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients (clinicaltrials.gov) - Jun 24, 2013
P0, N=25, Recruiting, Sponsor: Washington University School of Medicine
Initiation date: May 2010 --> Aug 2010
- || Enrollment change: Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding (clinicaltrials.gov) - Jun 23, 2013
P=N/A, N=78, Completed, Sponsor: Bayer
Initiation date: May 2010 --> Aug 2010 N=106 --> 78
- ||||||| Trial completion: A Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps (clinicaltrials.gov) - Jun 23, 2013
P3, N=121, Completed, Sponsor: Birmingham Women's NHS Foundation Trust
N=106 --> 78 Recruiting --> Completed
- Clinical: Factors Affecting the Prognosis of Patients With Endometrial Cancer (clinicaltrials.gov) - Jun 23, 2013
P=N/A, N=100, Recruiting, Sponsor: Far Eastern Memorial Hospital
- || Preclinical, Enrollment change: Perifollicular Doppler in Natural Cycle In Vitro Fertilization (clinicaltrials.gov) - Jun 20, 2013
P=N/A, N=160, Completed, Sponsor: OVO R & D
Recruiting --> Completed N=94 --> 160
- ||| Trial completion, Preclinical: Perifollicular Doppler in Natural Cycle In Vitro Fertilization (clinicaltrials.gov) - Jun 20, 2013
P=N/A, N=160, Completed, Sponsor: OVO R & D
N=94 --> 160 Recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg.
Trial withdrawal: OMLET: Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients (clinicaltrials.gov) - Jun 20, 2013
P4, N=0, Withdrawn, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Terminated --> Withdrawn
- leuprolide acetate for depot suspension / Generic mfg.
Enrollment change: OMLET: Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients (clinicaltrials.gov) - Jun 20, 2013
P4, N=0, Withdrawn, Sponsor: Weill Medical College of Cornell University
Terminated --> Withdrawn N=224 --> 0
- | Enrollment open: Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis (clinicaltrials.gov) - Jun 19, 2013
P2/3, N=60, Recruiting, Sponsor: Università degli Studi dell'Insubria
N=224 --> 0 Not yet recruiting --> Recruiting
- gemifloxacin mesylate / Generic mfg., azithromycin / Generic mfg., gentamicin sulfate / Generic mfg.
Trial completion, Combination therapy: Efficacy of Combination Therapies for Gonorrhea Treatment (clinicaltrials.gov) - Jun 19, 2013
P4, N=486, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial initiation date: Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Jun 19, 2013
P=N/A, N=114, Recruiting, Sponsor: British Columbia Cancer Agency
Recruiting --> Completed Initiation date: Jan 2008 --> Dec 2010
- || New P2/3 trial, Preclinical, Biopsy: A Study to Assess if Scratching the Lining of the Womb Prior to IVF Treatment Increases the Chances of Pregnancy (clinicaltrials.gov) - Jun 18, 2013
P2/3, N=160, Recruiting, Sponsor: Nottingham University Hospitals NHS Trust
- Enrollment closed: Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas (clinicaltrials.gov) - Jun 18, 2013
P=N/A, N=700, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Initiation date: Jan 2008 --> Dec 2010 Recruiting --> Active, not recruiting
- | pritelivir (AIC316) / AiCuris
Trial termination: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes (clinicaltrials.gov) - Jun 17, 2013
P2, N=91, Terminated, Sponsor: AiCuris GmbH & Co.KG
Recruiting --> Active, not recruiting Suspended --> Terminated
- | New P1/2 trial, HEOR: Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies (clinicaltrials.gov) - Jun 17, 2013
P1/2, N=60, Not yet recruiting, Sponsor: Sheba Medical Center
- ||| seribantumab (MM-121) / Elevation Oncology
Enrollment closed, Combination therapy, Metastases: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers (clinicaltrials.gov) - Jun 17, 2013
P2, N=210, Active, not recruiting, Sponsor: Merrimack Pharmaceuticals
Suspended --> Terminated Recruiting --> Active, not recruiting
- | clomifene citrate / Generic mfg.
New P2 trial: Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration (clinicaltrials.gov) - Jun 16, 2013
P2, N=134, Recruiting, Sponsor: Weill Medical College of Cornell University
- Trial suspension: Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer (clinicaltrials.gov) - Jun 16, 2013
P=N/A, N=110, Suspended, Sponsor: Emory University
Recruiting --> Active, not recruiting Recruiting --> Suspended
- veliparib (ABT-888) / AbbVie
Enrollment closed, Combination therapy, PARP Biomarker, Metastases: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 16, 2013
P1, N=24, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Suspended Recruiting --> Active, not recruiting
- RG4733 / Roche
Enrollment closed, Metastases: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 16, 2013
P2, N=37, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Completed --> Active, not recruiting
- Trial completion, Surgery: Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 16, 2013
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Completed --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: To Study Polycystic Ovary Syndrome in Taiwanese Women (clinicaltrials.gov) - Jun 13, 2013
P=N/A, N=390, Completed, Sponsor: Taipei Medical University WanFang Hospital
Active, not recruiting --> Completed N=300 --> 390
- Trial completion: To Study Polycystic Ovary Syndrome in Taiwanese Women (clinicaltrials.gov) - Jun 13, 2013
P=N/A, N=390, Completed, Sponsor: Taipei Medical University WanFang Hospital
N=300 --> 390 Recruiting --> Completed
- Enrollment change: Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome (clinicaltrials.gov) - Jun 12, 2013
P4, N=43, Completed, Sponsor: Line Cleemann
Recruiting --> Completed N=60 --> 43
- Trial completion: Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome (clinicaltrials.gov) - Jun 12, 2013
P4, N=43, Completed, Sponsor: Line Cleemann
N=60 --> 43 Active, not recruiting --> Completed
- |||| clindamycin phosphate / Generic mfg.
Trial completion: PREMEVA: Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Jun 11, 2013
P4, N=3105, Completed, Sponsor: University Hospital, Lille
Active, not recruiting --> Completed Recruiting --> Completed
- metformin / Generic mfg.
New P2 trial: A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women (clinicaltrials.gov) - Jun 11, 2013
P2, N=40, Recruiting, Sponsor: University of Arkansas
- Enrollment closed, Metastases, Biopsy: Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. (clinicaltrials.gov) - Jun 11, 2013
P=N/A, N=100, Active, not recruiting, Sponsor: Women and Infants Hospital of Rhode Island
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Avastin (bevacizumab) / Roche
Enrollment closed, Combination therapy: Irinotecan and Bevacizumab for Recurrent Ovarian Cancer (clinicaltrials.gov) - Jun 10, 2013
P2, N=30, Active, not recruiting, Sponsor: New York University School of Medicine
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment open: Trichomonas Vaginalis Repeat Infections Among HIV Negative Women (clinicaltrials.gov) - Jun 9, 2013
P4, N=2883, Recruiting, Sponsor: Tulane University Health Sciences Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| Enrollment open: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings (clinicaltrials.gov) - Jun 9, 2013
P=N/A, N=932, Recruiting, Sponsor: Children's Oncology Group
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- Enrollment change: Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Jun 9, 2013
P1/2, N=70, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Active, not recruiting --> Recruiting N=150 --> 70
- Trial completion: Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Jun 9, 2013
P1/2, N=70, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center
N=150 --> 70 Active, not recruiting --> Completed
- medroxyprogesterone injection / Generic mfg.
Trial termination, Surgery: Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer (clinicaltrials.gov) - Jun 6, 2013
P2, N=360, Terminated, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Completed --> Terminated
- New P4 trial: DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women (clinicaltrials.gov) - Jun 6, 2013
P4, N=30, Recruiting, Sponsor: Tulane University Health Sciences Center
- cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial withdrawal, HEOR: Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 (clinicaltrials.gov) - Jun 6, 2013
P=N/A, N=0, Withdrawn, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Withdrawn
- carboplatin / Generic mfg., cisplatin / Generic mfg., gemcitabine / Generic mfg.
Trial withdrawal: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin (clinicaltrials.gov) - Jun 6, 2013
P2, N=0, Withdrawn, Sponsor: Gynecologic Oncology Group
Completed --> Withdrawn Not yet recruiting --> Withdrawn
- cisplatin / Generic mfg.
Trial termination: Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva (clinicaltrials.gov) - Jun 6, 2013
P3, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Not yet recruiting --> Withdrawn Active, not recruiting --> Terminated
- Trial termination, HEOR: Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer (clinicaltrials.gov) - Jun 6, 2013
P=N/A, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Terminated Completed --> Terminated
- topotecan / Generic mfg., gemcitabine / Generic mfg.
Trial termination: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer (clinicaltrials.gov) - Jun 6, 2013
P1, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- Trial termination: Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer (clinicaltrials.gov) - Jun 6, 2013
P1, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Completed --> Terminated
- etoposide IV / Generic mfg.
Trial termination, Metastases: Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer (clinicaltrials.gov) - Jun 6, 2013
P2, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Completed --> Terminated Active, not recruiting --> Terminated
- cisplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment change, HEOR: Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 (clinicaltrials.gov) - Jun 6, 2013
P=N/A, N=0, Withdrawn, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Terminated N=40 --> 0
- carboplatin / Generic mfg., cisplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment change: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin (clinicaltrials.gov) - Jun 6, 2013
P2, N=0, Withdrawn, Sponsor: Gynecologic Oncology Group
N=40 --> 0 N=100 --> 0
- ||||| pavinetant (AZD4901) / AstraZeneca, Millendo Therap
New P2a trial: A Study of AZD4901 in Females With Polycystic Ovary Syndrome (clinicaltrials.gov) - Jun 5, 2013
P2a, N=56, Recruiting, Sponsor: AstraZeneca
- Norditropin (somatropin) / Novo Nordisk
Trial termination: Initiating Transdermal Estradiol Therapy in Turner's Syndrome (clinicaltrials.gov) - Jun 5, 2013
P1, N=1, Terminated, Sponsor: University of Chicago
N=100 --> 0 Recruiting --> Terminated; Poor accrual
- Norditropin (somatropin) / Novo Nordisk
Enrollment change: Initiating Transdermal Estradiol Therapy in Turner's Syndrome (clinicaltrials.gov) - Jun 5, 2013
P1, N=1, Terminated, Sponsor: University of Chicago
Recruiting --> Terminated; Poor accrual N=60 --> 1
- cisplatin / Generic mfg., amifostine / Generic mfg.
Enrollment change: Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer (clinicaltrials.gov) - Jun 4, 2013
P1/2, N=45, Completed, Sponsor: Radiation Therapy Oncology Group
N=60 --> 1 N=66 --> 45
- ||||| New P4 trial: EMR700623_535: Low-dose Gonal-f (clinicaltrials.gov) - Jun 4, 2013
P4, N=110, Recruiting, Sponsor: Merck KGaA
- |||| Enrollment open: EMR700623_535: Low-dose Gonal-f (clinicaltrials.gov) - Jun 3, 2013
P4, N=110, Recruiting, Sponsor: Merck KGaA
N=66 --> 45 Not yet recruiting --> Recruiting